1887
  1. Home
  2. Eurosurveillance
  3. Volume 27, Issue 11, 17/Mar/2022
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

When SARS-CoV-2 Omicron emerged in 2021, S gene target failure enabled differentiation between Omicron and the dominant Delta variant. In England, where S gene target surveillance (SGTS) was already established, this led to rapid identification (within ca 3 days of sample collection) of possible Omicron cases, alongside real-time surveillance and modelling of Omicron growth. SGTS was key to public health action (including case identification and incident management), and we share applied insights on how and when to use SGTS.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.11.2200143
2022-03-17
2024-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.11.2200143
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/11/eurosurv-27-11-2.html?itemId=/content/10.2807/1560-7917.ES.2022.27.11.2200143&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Enhancing readiness for Omicron (B.1.1.529): technical brief and priority actions for Member States. Geneva: WHO; 2021. Available from: https://www.who.int/docs/default-source/coronaviruse/2021-12-23-global-technical-brief-and-priority-action-on-omicron.pdf?sfvrsn=d0e9fb6c_8
  2. Ferguson N, Ghani A, Cori A, Hogan A, Hinsley W, Volz E, et al. Growth, population distribution and immune escape of Omicron in England. London: Imperial College London; 2021. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-49-Omicron
  3. Christie B. Covid-19: Early studies give hope omicron is milder than other variants. BMJ. 2021;375(3144):n3144.  https://doi.org/10.1136/bmj.n3144  PMID: 34949600 
  4. Furuse Y. Genomic sequencing effort for SARS-CoV-2 by country during the pandemic. Int J Infect Dis. 2021;103:305-7.  https://doi.org/10.1016/j.ijid.2020.12.034  PMID: 33333251 
  5. European Centre for Disease Control (ECDC). Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA. Stockholm: ECDC; 2021. Available from. https://www.ecdc.europa.eu/en/publications-data/detection-and-characterisation-capability-and-capacity-sars-cov-2-variants
  6. European Centre for Disease Control (ECDC) and World Health Organization Regional Office for Europe. (WHO/Europe). Methods for the detection and identification of SARS-CoV-2 variants - first update. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/methods-detection-and-characterisation-sars-cov-2-variants-first-update
  7. UK Health Security Agency (UKHSA). SARS-CoV-2 variants of concern and variants under investigation in England. Variant of concern: Omicron, VOC-21NOV-01 (B.1.1.529). Technical briefing 30. London: UKHSA; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038404/Technical_Briefing_30.pdf
  8. Willet BJ, Grove J, MacLean AA, Wilkie C, Logan N, De Lorenzo G, et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. MedRxiv. 2022.01.03.21268111.  https://doi.org/10.1101/2022.01.03.21268111 . https://doi.org/10.1101/2022.01.03.21268111 
  9. Erster O, Beth-Din A, Asraf H, Levy V, Kabat A, Mannasse B, et al. Specific detection of SARS-COV-2 B.1.1.529 (Omicron) variant by four RT-qPCR differential assays. MedRxiv. 2021.12.07.21267293.  https://doi.org/10.1101/2021.12.07.21267293 . https://doi.org/10.1101/2021.12.07.21267293 
  10. Harper H, Burridge A, Winfield M, Finn A, Davidson A, Matthews D, et al. Detecting SARS-CoV-2 variants with SNP genotyping. PLoS One. 2021;16(2):e0243185.  https://doi.org/10.1371/journal.pone.0243185  PMID: 33626040 
  11. COVID-19 Genomics UK (COG-UK) [email protected]. An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe. 2020;1(3):e99-100.  https://doi.org/10.1016/S2666-5247(20)30054-9  PMID: 32835336 
  12. Hripcsak G. Visualizing the operating range of a classification system. J Am Med Inform Assoc. 2012;19(4):529-32.  https://doi.org/10.1136/amiajnl-2011-000633  PMID: 22249966 
  13. UK Health Security Agency (UKHSA). SARS-CoV-2 variants of concern and variants under investigation in England. Omicron VOC-21NOV-01 (B.1.1.529) update on cases, S gene target failure and risk assessment. London: UKHSA; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_case_update_FINAL.pdf
  14. Giraudon H, Djemai M, Auvray C, de Rougemont A, Belliot G, Bour JB, et al. Local emergence of a del HV69-70 SARS-CoV-2 variant in Burgundy, France. Pathogens. 2022;11(2):124.  https://doi.org/10.3390/pathogens11020124  PMID: 35215068 
  15. Essex County Council. Omicron Covid-19 case. Colchester: Essex County Council; 2021. Available from: https://www.essex.gov.uk/news/omicron-covid-19-case
  16. Barnard RC, Davies N, Pearson CAB, Jit M, Edmunds JW. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. MedRxiv. 2021.12.15.21267858. https://doi.org/10.1101/2021.12.15.21267858
  17. UK Health Security Agency (UKHSA). SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 37. UK Government. London: UKHSA; 2022. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1057359/Technical-Briefing-37-25February2022.pdf
Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Paula+B+Blomquist&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Blomquist Paula B</a>, <a href="/search?value1=Jessica+Bridgen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bridgen Jessica</a>, <a href="/search?value1=Neil+Bray&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bray Neil</a>, <a href="/search?value1=Anne+Marie+O%E2%80%99Connell&option1=author&noRedirect=true" class="nonDisambigAuthorLink">O’Connell Anne Marie</a>, <a href="/search?value1=Daniel+West&option1=author&noRedirect=true" class="nonDisambigAuthorLink">West Daniel</a>, <a href="/search?value1=Natalie+Groves&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Groves Natalie</a>, <a href="/search?value1=Eileen+Gallagher&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gallagher Eileen</a>, <a href="/search?value1=Lara+Utsi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Utsi Lara</a>, <a href="/search?value1=Christopher+I+Jarvis&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jarvis Christopher I</a>, <a href="/search?value1=Jo+L+Hardstaff&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hardstaff Jo L</a>, <a href="/search?value1=Chloe+Byers&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Byers Chloe</a>, <a href="/search?value1=Soeren+Metelmann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Metelmann Soeren</a>, <a href="/search?value1=David+Simons&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Simons David</a>, <a href="/search?value1=Asad+Zaidi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zaidi Asad</a>, <a href="/search?value1=Katherine+A+Twohig&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Twohig Katherine A</a>, <a href="/search?value1=Bethan+Savagar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Savagar Bethan</a>, <a href="/search?value1=Alessandra+L%C3%B8chen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Løchen Alessandra</a>, <a href="/search?value1=Cian+Ryan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ryan Cian</a>, <a href="/search?value1=Katie+Wrenn&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Wrenn Katie</a>, <a href="/search?value1=Mar%C3%ADa+Saavedra-Campos&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Saavedra-Campos María</a>, <a href="/search?value1=Zahidul+Abedin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abedin Zahidul</a>, <a href="/search?value1=Isaac+Florence&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Florence Isaac</a>, <a href="/search?value1=Paul+Cleary&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cleary Paul</a>, <a href="/search?value1=Richard+Elson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Elson Richard</a>, <a href="/search?value1=Roberto+Vivancos&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vivancos Roberto</a>, <a href="/search?value1=Iain+R+Lake&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lake Iain R</a></span>. Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021. <a href="/content/ecdc">Euro Surveill.</a> 2022;27(11):pii=2200143. <a href="https://doi.org/10.2807/1560-7917.ES.2022.27.11.2200143" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2022.27.11.2200143</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 09 Feb 2022;&nbsp;&nbsp; <span class="generated">Accepted</span>: 17 Mar 2022 </span> </p>
/content/10.2807/1560-7917.ES.2022.27.11.2200143
/content/10.2807/1560-7917.ES.2022.27.11.2200143
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error